Conference abstract · 7 Nov 2016
Conference abstractPublished 7 Nov 2016
Epigenomic profile in dementia-related disorders
EuroEspes Biomedical Research Center, Spain Camilo Jose Cela University, Spain
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cerebrovascular and neurodegenerative disorders are among the leading causes of death in the World, according to the WHO. A number of these disorders are characterized by the onset of dementia. AlzheimerâÂ?Â?s disease (AD) is the major cause of dementia in Western countries, affecting 45-60% of the population, followed by vascular dementia (VD) and mixed dementia (MD) with prevalence of 30-40% and 10-20%, respectively. Epigenomic mechanisms (DNA methylation, chromatin remodeling/histone modifications, miRNA regulation) are involved in the transcriptional and post-translational regulation of genes in physiological and pathological conditions leading to potentially reversible phenotypes. Epigenetics is sited among the major regulatory elements that control metabolic pathways at the molecular level, which allows a deeper study of complex multifactorial diseases, such as dementia-related disorders. Therefore, epigenomic signatures may help in the prediction, early diagnosis and prognosis of those pathologies. Human exome sequencing and genome-wide association studies have linked several neurobiological disorders to epigenetically regulated genes. We have evaluated the main epigenetic mechanisms affecting genes associated with dementia-related disorders such as AlzheimerâÂ?Â?s disease (AD), dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD). We also evaluated genes related with lipid metabolism and vascular physiology which are not directly involved in brain disorders, although their epigenetic profile may be nevertheless associated with dementia-related disorders. Epigenetic drug discovery, application of pharmacoepigenomic procedures for personalized therapeutics, novel approaches to decode and resolve drug resistance and targeting miRNAs in prevention and treatment of dementia-related disorders are promising areas of future development.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 19 Jun 2025
Metabolic Stress and Microglial Dysfunction in Dementia-Related Cognitive Decline
Perspective · 14 Sep 2022
Posttraumatic stress jumble with optionalpsychotic features (PTSD-SP): The study of disease transmission and Pathophysiology of Dementia-Related Psychosis.
Conference abstract · 8 Aug 2018
Dementia-related agitation: A review of non-drug interventions and analysis of risks and benefits of drug therapy
Review article · 22 May 2017
Treatment of Dementia-related Symptoms with Japanese Traditional Medicine (Kampo): A Review of Clinical Studies
More from this journal
The newest in Human Genetics & Embryology.
Commentary · 29 Nov 2025
Chromosomal Abnormalities: Impact Across Human Health
Commentary · 29 Nov 2025
Down Syndrome: Complexities, Comorbidities, and Care
Brief report · 29 Nov 2025
Turner Syndrome: Comprehensive, Lifelong, Holistic Care
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHuman Genetics & Embryology
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Oscar Teijido Hermida”
- BylineArticles whose byline prints “Juan C Carril”
- BylineArticles whose byline prints “Ivan Tellado”
- BylineArticles whose byline prints “Ramon Cacabelos”

